Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection: For the last few decades, Calcineurin inhibitors (CNI)-based therapy has been the pillar of immunosuppression for… #immunology https://t.co/1LmjwBgP8
Happy to share our perspective on strategies to maximize the therapeutic potential of costimulation blockade in transplant rejection: https://t.co/CqVvaKb6Ic Great effort of Dr. Marcos Iglesias and beautiful collaboration with @clarsenEmory and Dr. Dan Br
New Research: Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection: For the last few decades, Calcineurin inhibitors (CNI)-based therapy has been the pillar of immunosuppression for… https://t.co/WEOudfA